Preview

Pharmacogenetics and Pharmacogenomics

Advanced search

Some molecular genetic mechanisms of the obesity and metabolic syndrome

Abstract

The article discusses the relevance of studying the mechanisms of obesity as a multidisciplinary problem. Variants of polymorphism of genes - candidates of excessive body weight and obesity, as well as associated states are described. The mechanisms of monogenic obesity, mutations of leptin - melanocortin system are analyzed. Genetic mechanisms of polygenic forms of obesity, polymorphic variants of lipid exchange genes, polymorphic variants of genes involved in the formation of food behavior, inclination to overeating, snacks, fatty acid metabolism, etc. are discussed. The approaches to personalization of practical recommendations for the prevention of obesity and metabolic syndrome in patients with a genetic predisposition are discussed. Overview of the approaches to choosing a personalized diet and exercise for this category of patients using genetic tests.

About the Authors

G. I. Lifshits
Irkutsk Scientific Center of Siberian Brunch of the Russian Academy of Science; Institute of chemical biology and fundamental medicine, Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS)
Russian Federation


N. V. Kokh
Institute of chemical biology and fundamental medicine, Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS)
Russian Federation


V. V. Kireeva
Irkutsk Scientific Center of Siberian Brunch of the Russian Academy of Science; Federal state budgetary institution of health care hospital of the Irkutsk Scientific center of the Siberian branch of the Russian Academy of Sciences
Russian Federation


K. A. Apartsin
Irkutsk Scientific Center of Siberian Brunch of the Russian Academy of Science
Russian Federation


References

1. Шальнова С.А., Деев А.Д. Масса тела у мужчин и женщин (результаты обследования российской, национальной, представительной выборки населения). Кардиоваскуляр. терапия и профилактика. 2008; 7: 60 63.

2. Eckel R.H., York D. A, Rossner S. et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation. 2004; 110 (18): 2968 2975.

3. Heitmann B.L., Koplan J., Lissner L. Childhood obesity: successes and failures of preventive interventions. Nutr. Rev. 2009; 67 (1): 89-93.

4. Towfighi A., Zheng L., Ovbiagele B. Weight of the obesity epidemic: rising stroke rates among middle-aged women in the United States. Stroke. 2010; 41 (7): 1371 1375.

5. Сорвачева Т.Н., Петеркова В.А., Титова И.Н. и др. Ожирение у подростков. Альтернативные подходы диетотерапии. Лечащий врач. 2006; 4: 50-54.

6. Логачева О.С. Особенности сосудистого ремоделирования у детей с избыточной массой тела: автореф. дис.. канд. мед. наук. М.: 2010.

7. Pi-Sunyer F.X. The obesity epidemic: pathophysiology and consequences of obesity. Obes. Res. 2002; 10 (2): 97-104.

8. Speakman J.R. Obesity: the integrated roles of environment and genetics. J. Nutr. 2004; 134 (8): 2090 2105.

9. Choquet Н., Meyre D. Molecular Basis of Obesity: Current Status and Future Prospects. Curr. Genomics. 2011; 12 (3): 154-168.

10. Дедов И.И., Мельниченко Г.А. Ожирение: этиология, патогенез, клинические аспекты. 2002; 92.

11. Ройтберг Г.Е. Метаболический синдром. М.: МЕДпресс-информ, 2007; 224. Roitberg G.E. Metabolic syndrome. M: MEDpress-Inform, 2007; 224.

12. Синицын П.А., Щербакова М.Ю., Ларионова В.И. и др. Метаболический синдром у детей. Педиатрия. 2008; 87 (5): 124-126.

13. Чибисов С.М., Рапопорт С.И., Колесников Д.Б. и др. Метаболический синдром: больше вопросов, чем ответов. Клиническая медицина. 2008; 6: 30-34.

14. Ровда Ю.И., Миняйлова H.H., Сундукова E.Л. Толщина эпикардиального жира как маркер висцерального жироотложения и ранних кардиоваскулярных осложнений ожирения у детей и подростков. Педиатрия. 2010; 89 (5): 51-56.

15. Кузьмина-Крутицкая С.Р. Метаболический синдром у женщин: авт. дис..канд. мед. наук. СПб.: 2011.

16. Farooq S., Orahilly S. Genetics of obesity in humans. Endocrin. Reviews. 2006; 27 (7): 710 718.

17. Романцева Т. И. Эпидемия ожирения: очевидные и вероятные причины. Ожирение и метаболизм. 2011; 1: 5-19.

18. Бирюкова Е.В. Молекулярно-генетические, гормонально-метаболические и клинические аспекты метаболического синдрома: авт. дис.. докт. мед. наук. М.: 2009.

19. Loos R.J., Yeo G.S. The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014; 10 (1): 51-61.

20. Tung C.L., Gulati P., Liu C.-H. et al. FTO is necessary for the induction of leptin resistance by high-fat feeding. Mol Metab. 2015; 4 (4): 287 298.

21. Imaizumi T., Ando M., Nakatochi M. et al. Effect of dietary energy and polymorphisms in BRAP and GHRL on obesity and metabolic traits. Obes Res Clin Pract. 2016.

22. You Y., Yu Y., Wu Y. et al. Association Study between Ghrelin Gene Polymorphism and Metabolic Syndrome in a Han Chinese Population. Clin Lab. 2017; 63 (1): 175-181.

23. Bu G. Apolipoprotein E. and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009; 10 (5): 333-344.

24. Smith C.E., Tucker K.L., Lai C.-Q., Parnell L.D. et al. Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin. Obesity (Silver Spring). 2010; 18 (2): 327-332.

25. Кох Н.В., Лифшиц Г.И., Воронина Е.Н. Возможности анализа полиморфизма генов липидного обмена для выявления факторов риска атеросклероза. Российский кардиологический журнал. 2014; (10): 53-57.

26. Esteves A., Knoll-Gellida A., Canclini L. et al. Fatty acid-binding proteins have the potential to channel dietary fatty acids into enterocyte nuclei. J Lipid Res. 2015; 57 (2).

27. Liu P., Yu D., Jin X. et al. The association between the FABP2 Ala54Thr variant and the risk of type 2 diabetes mellitus: a meta-analysis based on 11 case-control studies. Int J. Clin Exp Med. 2015; 8 (4): 5422-5429.

28. Khattab S.A., Abo-Elmatty D.M., Ghattas M.H. et al. Intestinal fatty acid binding protein Ala54Thr polymorphism is associated with peripheral atherosclerosis combined with type 2 diabetes mellitus. J Diabetes. 2016.

29. Berna G., Oliveras-Lopez M.J., Jurado-Ruiz E. et al. Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis. Nutrients. 2014; 6 (11): 5338-5369.

30. Neeha V.S., Kinth P. Nutrigenomics research: a review. J Food Sci Technol. 2013; 50 (3): 415-428.

31. Киреева В.В., Кох Н.В., Лифшиц Г.И., Апарцин К.А. Дисфункция эндотелия как краеугольный камень сердечно-сосудистых событий: молекулярно- и фармакогенетические аспекты. Российский кардиологический журнал. 2014; (10): 64-68.


Review

For citations:


Lifshits G.I., Kokh N.V., Kireeva V.V., Apartsin K.A. Some molecular genetic mechanisms of the obesity and metabolic syndrome. Pharmacogenetics and Pharmacogenomics. 2017;(1):5-9. (In Russ.)

Views: 1026


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2588-0527 (Print)
ISSN 2686-8849 (Online)